INFUSYSTEM HOLDINGS, INC Tax Withholding Paid on Stock Awards
INFUSYSTEM HOLDINGS, INC (INFU) reported Tax Withholding Paid on Stock Awards of $775.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $610.00K, a 165.22% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $165.00K, a 27.63% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $69.00K, a 63.87% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $578.00K, a 57700.00% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC payment, tax withholding, share-based payment arrangement for fiscal 2025 was $1.10M, a 35.42% increase from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC payment, tax withholding, share-based payment arrangement for fiscal 2024 was $816.00K, a 29.53% decline from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC payment, tax withholding, share-based payment arrangement for fiscal 2023 was $1.16M, a 2.93% decline from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC payment, tax withholding, share-based payment arrangement for fiscal 2022 was $1.19M, a 1.79% increase from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $610.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $775.00K 10-Q · filed 2026-08-04 | $844.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.42M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $165.00K 10-Q · filed 2026-05-08 | $234.00K derived: sum of 2 quarters · filed 2026-05-08 | $812.00K derived: sum of 3 quarters · filed 2026-05-08 | $1.04M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $647.00K derived: sum of 2 quarters · filed 2026-02-27 | $877.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.10M 10-K · filed 2026-02-27 |
| 2025-09-30 | $578.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $808.00K derived: sum of 2 quarters · filed 2026-08-04 | $1.04M 10-Q · filed 2025-11-04 | $1.23M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $458.00K 10-Q · filed 2026-08-04 | $649.00K derived: sum of 3 quarters · filed 2026-08-04 | $650.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $228.00K 10-Q · filed 2026-05-08 | $419.00K derived: sum of 2 quarters · filed 2026-05-08 | $420.00K derived: sum of 3 quarters · filed 2026-05-08 | $679.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $191.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $192.00K derived: sum of 2 quarters · filed 2026-02-27 | $451.00K derived: sum of 3 quarters · filed 2026-02-27 | $816.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $260.00K derived: sum of 2 quarters · filed 2025-11-04 | $625.00K 10-Q · filed 2025-11-04 | $626.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $259.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $624.00K 10-Q · filed 2025-08-05 | $625.00K derived: sum of 3 quarters · filed 2025-08-05 | $1.26M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $365.00K 10-Q · filed 2025-05-08 | $366.00K derived: sum of 2 quarters · filed 2025-05-08 | $1.00M derived: sum of 3 quarters · filed 2025-05-08 | $1.20M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $635.00K derived: sum of 2 quarters · filed 2025-03-11 | $834.00K derived: sum of 3 quarters · filed 2025-03-11 | $1.16M 10-K · filed 2025-03-11 |
| 2023-09-30 | $634.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $833.00K derived: sum of 2 quarters · filed 2024-11-08 | $1.16M 10-Q · filed 2024-11-08 | $1.65M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $199.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $523.00K 10-Q · filed 2024-08-09 | $1.02M derived: sum of 3 quarters · filed 2024-08-09 | $1.08M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $324.00K 10-Q · filed 2024-05-09 | $819.00K derived: sum of 2 quarters · filed 2024-05-09 | $878.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.46M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $495.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $554.00K derived: sum of 2 quarters · filed 2024-04-10 | $1.14M derived: sum of 3 quarters · filed 2024-04-10 | $1.19M 10-K · filed 2024-04-10 |
| 2022-09-30 | $59.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $644.00K derived: sum of 2 quarters · filed 2023-11-09 | $698.00K 10-Q · filed 2023-11-09 | $729.00K derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-06-30 | $585.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $639.00K 10-Q · filed 2023-08-09 | $670.00K derived: sum of 3 quarters · filed 2024-04-10 | $670.00K derived: sum of 4 quarters · filed 2024-04-10 |
| 2022-03-31 | $54.00K 10-Q · filed 2023-05-09 | $85.00K derived: sum of 2 quarters · filed 2024-04-10 | $85.00K derived: sum of 3 quarters · filed 2024-04-10 | $661.00K derived: sum of 4 quarters · filed 2024-04-10 |
| 2021-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $31.00K derived: sum of 2 quarters · filed 2024-04-10 | $607.00K derived: sum of 3 quarters · filed 2024-04-10 | $1.17M 10-K · filed 2024-04-10 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $576.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.14M 10-Q · filed 2022-11-08 | $1.59M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $576.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $1.14M 10-Q · filed 2022-08-04 | $1.59M derived: sum of 3 quarters · filed 2023-03-16 | $2.11M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-03-31 | $565.00K 10-Q · filed 2022-05-05 | $1.01M derived: sum of 2 quarters · filed 2023-03-16 | $1.54M derived: sum of 3 quarters · filed 2023-03-16 | $1.85M derived: sum of 4 quarters · filed 2023-03-16 |
| 2020-12-31 | $445.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $973.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.29M derived: sum of 3 quarters · filed 2023-03-16 | $1.71M 10-K · filed 2023-03-16 |
| 2020-09-30 | $528.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $843.00K derived: sum of 2 quarters · filed 2021-11-15 | $1.27M 10-Q · filed 2021-11-15 | $1.69M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | $315.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $741.00K 10-Q · filed 2021-08-12 | $1.16M derived: sum of 3 quarters · filed 2022-03-15 | $1.25M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $426.00K 10-Q · filed 2021-05-10 | $848.00K derived: sum of 2 quarters · filed 2022-03-15 | $935.00K derived: sum of 3 quarters · filed 2022-03-15 | $1.11M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | $422.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $509.00K derived: sum of 2 quarters · filed 2022-03-15 | $680.00K derived: sum of 3 quarters · filed 2022-03-15 | $717.00K 10-K · filed 2022-03-15 |
| 2019-09-30 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $258.00K derived: sum of 2 quarters · filed 2020-11-13 | $295.00K 10-Q · filed 2020-11-13 | $360.00K derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $208.00K 10-Q · filed 2020-08-14 | $273.00K derived: sum of 3 quarters · filed 2020-08-14 | $273.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $37.00K 10-Q · filed 2020-05-15 | $102.00K derived: sum of 2 quarters · filed 2020-05-15 | $102.00K derived: sum of 3 quarters · filed 2020-05-15 | |
| 2018-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $65.00K derived: sum of 2 quarters · filed 2020-03-30 | $70.00K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $5.00K 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $5.00K 10-Q · filed 2019-08-14 | |||
| 2017-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $30.00K derived: sum of 2 quarters · filed 2019-03-22 | $38.00K derived: sum of 3 quarters · filed 2019-03-22 | $58.00K 10-K · filed 2019-03-22 |
| 2017-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $7.00K derived: sum of 2 quarters · filed 2018-11-13 | $27.00K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $28.00K 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $20.00K 10-Q · filed 2018-05-14 | |||
| 2016-12-31 | $75.00K 10-K · filed 2018-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |